Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML)

✍ Scribed by Weh, H. J. ;Kuse, R. ;Hoffmann, R. ;Seeger, D. ;Suciu, S. ;Kabisch, H. ;Ritter, J. ;Hossfeld, D. K.

• Book ID: 104721621
• Publisher: Springer-Verlag
• Year: 1988
• Weight: 654 KB
• Volume: 56
• Category: Article
• ISSN: 1432-0584
• DOI: 10.1007/bf00321055

✦ Synopsis

Between 1981 and 1986 cytogenetic studies of bone marrow and/or blood cells in 139 patients with de novo acute myeloid leukemia (AML) were performed. The overall incidence of chromosomal aberrations was 53%, and this was not significantly influenced by sex, age nor the FAB classification. The aberrations most often found were: complex anomalies (n = 13), t(8; 21) (n = 10), trisomy 8 (n = 9), monosomy 7 (n = 6), monosomy 5, 5q-, trisomy 11, 12p- (n = 4) and trisomy 6, 11q-, inv (n = 3). The prognostic significance of chromosomal findings was evaluated in 112 patients treated by combination chemotherapy. The chromosomal status NN, AN, AA did neither significantly influence complete remission rate (NN: 68%, AN: 71%, AA: 60%) nor mean survival (NN: 24, AN: 26.6, AA: 35.6 months). On the other hand, certain types of chromosomal anomalies were of prognostic value. CR was obtained in all 10 patients with t(8; 21) but only in 2 out of 9 patients with complex aberrations. Median duration of CR in patients with t(8; 21) was significantly longer than in patients with a normal karyotype (30 vs 7 months).